Safety and efficacy of drug-eluting stents

Rev Cardiovasc Med. 2005:6 Suppl 1:S22-30.

Abstract

This review characterizes the relative effectiveness and safety of drug-eluting stents (DES) compared to bare metal stents. The data evaluated will include clinical and angiographic outcomes from randomized clinical trials as well as observational databases and registries including RESEARCH, e-Cypher, and DYNAMIC, which typically include a much broader spectrum of patients. In addition, specific patient subsets, including those patients with multivessel coronary disease, will be evaluated.

Publication types

  • Review

MeSH terms

  • Angioplasty, Balloon, Coronary
  • Blood Vessel Prosthesis Implantation
  • Coated Materials, Biocompatible / adverse effects
  • Coated Materials, Biocompatible / therapeutic use*
  • Coronary Angiography
  • Coronary Artery Disease / pathology
  • Coronary Artery Disease / therapy*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Paclitaxel / therapeutic use
  • Randomized Controlled Trials as Topic
  • Registries
  • Safety
  • Sirolimus / therapeutic use
  • Stents* / adverse effects
  • Treatment Outcome

Substances

  • Coated Materials, Biocompatible
  • Immunosuppressive Agents
  • Paclitaxel
  • Sirolimus